New drugs for bowel cancer

An immunotherapy drug, pembrolizumab, has shown the potential to melt away tumours in bowel cancer patients, as per a new study.

Today a new drug will become available for patients with bowel cancer as part of a national clinical trial; based on a scientific discovery

Chemotherapy for small bowel cancer​​ The drugs most commonly used to treat small bowel cancer are: fluorouracil (5FU) capecitabine (Xeloda)

This follows news in May when NICE also approved the use of drug pembrolizumab, which is available as a first line treatment for some people with advanced bowel cancer. Advanced bowel cancer is when cancer has spread to other parts of the body. Both of the new recommendations are for a type of targeted treatment called immunotherapy

A new drug has shown promise in slowing the regrowth of tumours among some bowel cancer patients, according to new findings of a major trial

Years of advocacy from Bowel Cancer New Zealand (NZ) and other groups calling for new bowel cancer drugs has led to a funding announcement

Chemotherapy for small bowel cancer​​ The drugs most commonly used to treat small bowel cancer are: fluorouracil (5FU) capecitabine (Xeloda)

An immunotherapy drug, pembrolizumab, has shown the potential to melt away tumours in bowel cancer patients, as per a new study.

chemotherapy continues to be highly effective in treating bowel cancer in many patients. bowel cancer, but not all bowel cancers will respond to these drugs.